ArticleCurrent radiopharmaceuticals2025
Prediction of Recurrence using a Stacked Denoising Autoencoder and Multifaceted Feature Analysis of Pretreatment MRI in Patients with Nasopharyngeal Carcinoma.
Article in Current radiopharmaceuticals, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Oncotype DX: Clinical Utility, Evidence, and Future Trends in Personalized Breast Cancer Management.International journal of cancer · 2026Review
- Integrating single-cell transcriptomics to construct an oncogene-driven prognostic model and elucidate metabolic-immune crosstalk in hepatocellular carcinoma.Molecular & cellular oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionNasopharyngeal Carcinoma (NPC) exhibits high incidence in southern China. Despite improved survival with intensity-modulated radiotherapy (IMRT), 10%-20% of patients experience local recurrence. Traditional TNM staging fails to reflect tumor heterogeneity, necessitating robust recurrence prediction models. This study aimed to develop an MRIbased NPC recurrence prediction model by integrating radiomics, deep learning, and clinical features.
methodsA total of 184 pathologically confirmed NPC patients receiving radical radiotherapy were included. After propensity score matching (1:1), 136 cases were analyzed. Stacked denoising autoencoder (SDAE) extracted deep features from contrast-enhanced T1-weighted MRI. Radiomic features (morphology, texture, first-order statistics), clinical parameters (gender, age, TNM stage), and SDAE features were combined to construct 12 models using SVM, MLP, logistic regression (LR), and random forest (RF). Performance was evaluated via AUC, accuracy, sensitivity, and specificity, with external validation (91 cases).
resultsModel 1 (radiomics + SDAE + clinical features + SVM) achieved the highest AUC (0.89, 95% CI: 0.84-0.93), accuracy (81.5%), sensitivity (67.3%), and specificity (97.9%). External validation showed AUC 0.83, sensitivity 88.9%, and specificity 78%. The DeLong test confirmed no significant AUC difference between internal and external cohorts (P >0.05). DISCUSSION: The fusion of SDAE-enhanced features outperformed traditional radiomics. SVM demonstrated optimal performance in small samples, likely due to its high-dimensional feature handling and anti-overfitting capability. Limitations include single-center retrospective design and lack of functional imaging (DWI/PET) or molecular markers (EBV-DNA). Future multicenter prospective studies and multimodal data integration are warranted to enhance biological interpretability and clinical utility.
conclusionThis model provides a tool for early recurrence risk stratification and personalized therapy optimization, advancing precision medicine in NPC management.
Indexed as
Identifiers
40237056What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.